Schedule 13D ownership disclosure

Oramed Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 68403P203

Event date: 2016-08-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-17-001320
Form type
SC 13D
Filer
ORAMED PHARMACEUTICALS INC.
CIK
CIK 1176309
Filed
Feb 14, 2017
Reporting period
Aug 30, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub